Can a new cement save teeth with deep decay better than the standard?

NCT ID NCT06256601

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether a calcium silicate cement outperforms the standard calcium hydroxide material when used to treat deep cavities close to the tooth's nerve. Adults aged 18 to 45 with at least one deep cavity will receive one of the two materials after partial decay removal. Researchers will check the restorations for fractures, sensitivity, and signs of further decay over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
calcium silicate cement (Theracal) compared to calcium hydroxide (Dycal)
What this could lead to
If calcium silicate proves more effective, it could become a preferred material for preserving tooth vitality in deep cavities.
What could go wrong
This is a small, early-stage trial with 80 participants, so results may not apply broadly. Both materials are already in use, so major breakthroughs are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP CARIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hacettepe University

    Ankara, 06100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.